Monitoring Agency Report for the quarter ended December 31, 2025
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences has submitted a Monitoring Agency Report to the stock exchanges for the third quarter of FY26 (October–December 2025). This is a routine compliance filing required by SEBI from companies that have raised funds through a public issue, rights issue, or qualified institutional placement. The report reviews whether the company has used the money raised from its earlier fund-raising activity in line with the purposes disclosed to investors. Specific details on issue size, amount utilised, and deviations (if any) are not available from the headline alone and would be contained in the actual report document.
This is a regulatory compliance disclosure rather than a business update, so it is unlikely to move the stock price on its own. Investors should check the report for any flags on diversion of funds, delays in deployment, or changes in the stated use of proceeds, as these could raise governance concerns.